Federal contractor · public award history

CERUS CORPORATION

UEIKJJQRRLY2FL5CAGE1PVJ6CONCORD, CALIFORNIA

Parent: CERUS CORPORATION KJJQRRLY2FL5

Awards we know about
7
Typical size
$115,899
Middle of their public awards
Dollars on those awards
$228.87M

Most of their awards we can see fall roughly between $22,148 and $21.61M.

From official USAspending contract records — not a capability rating, past-performance score, or recommendation to team or bid.

Awarding agencies

  • Department of Health and Human Services (7)

Industries & product codes

Award history

  • Department of Health and Human Services$115,899
    Sep 29, 2025PIID 75N90025P00719NAICS 334516PSC 6640AWARDUSAspending ↗

    25-007944 INTERCEPT PLATELET PROCESSING SETS

  • Department of Health and Human Services$185.47M
    Sep 21, 2025PIID HHSO100201600009CNAICS 541711PSC AN13AWARDUSAspending ↗

    CERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT). IGF::OT::IGF

  • Department of Health and Human Services$11.11M
    Jul 24, 2025PIID 75F40120C00158NAICS 325412PSC AN11AWARDUSAspending ↗

    BAA PROPOSAL EETWP33 DEVELOPMENT OF AN OPTIMIZED PATHOGEN INACTIVATION PROCESS FOR WHOLE BLOOD

  • Department of Health and Human Services$15,372
    Jul 8, 2025PIID 75N90025P00572NAICS 811210PSC J066AWARDUSAspending ↗

    INTERCEPT BLOOD SYSTEM ILLUMINATORS PREVENTATIVE MAINTENANCE AGREEMENT: PERIOD OF PERFORMANCE: 07/15/2025-07/14/2025

  • Department of Health and Human Services$14,925
    May 7, 2025PIID 75N90025P00456NAICS 334516PSC J066AWARDUSAspending ↗

    (R) CERUS CORPORATION:1188061 [25-006114]

  • Department of Health and Human Services$28,925
    Apr 1, 2025PIID 75N90025P00355NAICS 334516PSC 6640AWARDUSAspending ↗

    INTERCEPT PLATELET PROCESSING SET WITH DUAL STORAGE CONTAINERS FOR THE DEPARTMENT OF TRANSFUSION MEDICINE.

  • Department of Health and Human Services$32.12M
    Mar 24, 2025PIID 75A50124C00046NAICS 541714PSC 6505AWARDUSAspending ↗

    LICENSE PATHOGEN REDUCTION TECHNOLOGY (PRT) FOR RED BLOOD CELL (RBC) COMPONENTS TO REDUCE THE RISK OF TRANSFUSION-TRANSMITTED INFECTION (TTI) BY RECOGNIZED, EMERGING, EPIDEMIC, AND ENDEMIC PATHOGENS THAT IS CAPABLE OF TREATING OVER 10 MILLION RBC COM

Intelligence only — not legal advice, not a past-performance evaluation, and not a recommendation to team or bid. Verify on USAspending and SAM.gov.

Related open government contracts

Industry 334516

Open SAM.gov notices in industries where this company has public awards — not exclusive work for this firm.